• Both intravenous and subcutaneous treatments were ell accepted by patients. The convenience of treatment at home and the non-interference with daily routine were the main reasons to prefer the subcutaneous administration. Intravenous administration at the hospital was preferred because patients related it to an improvement in safety, the perception of a faster action and the reassuring effect of the doctor's presence.
• Patients were willing to accept treatments with lower efficacy or greater side effects risks if these treatments had lower duration or frequency. Table 2 . Selected studies related to patients´preferences for RA treatment characteristics
Preferences for treatment decision-making process participation
• Most RA patients preferred shared decision-making. They valued the expertise of the doctor but also wanted to be part of the decision-making process because they wanted to have some level of control and evaluate the doctor's treatment advice.
• RA-patients' preference for involvement in the decision-making was negatively associated with patients' age but positively associated with RA knowledge.
• Unawareness of having a choice to participate in the decision making was the main barrier for patients' participation in it.
• Most of patients required more information related to their treatment and the disease. Levels of evidence of each study were established based on the Oxford Centre for Evidence-Based Medicine (CEBM) levels of evidence iii .
RESULTS
The search strategy resulted in 1,156 citations. 1,114 of them were excluded as duplicates or clearly not relevant. After inclusion/exclusion criteria application, 15 studies accomplished the selection criteria ( Figure 1 ). • Patients who were moderately affected by RA were more likely to consider and discuss the pros and cons related to new treatment alternatives.
• Subjective numeracy was associated with younger, but not older patients' preference for the status quo.
• Treatment outcomes prioritization was influenced by the severity of symptoms and impairments, adaptation to the disease, external resources and stressors, and social expectations.
• Less pain, joint damage or fatigue, doing daily life activities and more mobility were the top five priority outcomes over 60 treatment outcomes. To compare preferences and injection forces using a conventional and a new ergonomic syringe
Müller-Ladner et al. 2010, Germany (2c)
Open, comparative, within-patient controlled, multicentre study
To determine preferences, satisfaction, usability and local tolerability of two sc administrated MTX formulations: medium vs. high-concentration
Scarpato et al. 2010, Italy (2c)
Preference study base on a self-administered questionnaire
To assess the preferences and the determinants of patients' choice for iv or sc administration
Barton et al. 2009, USA (5) Review
To examine the current literature on patients' preferences, satisfaction, and adherence to the biologic DMARDs for RA treatment Qualitative study: semistructured interviews
To describe patients' motive for wanting to be involved in medical decision-making
Schildmann et al. 2013, Germany (5)
Qualitative study: semistructured interviews)
To elicit the perceptions and preferences regarding information and participation in treatment decision-making • 3 related to patients' preferences for treatment status-quo and treatment outcomes.
• 9 related to patients' preferences for RA treatment characteristics 
